Start free

ImmunityBio, Inc. (IBRX) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 6, 2026.

Filings shown
13
Open-market buys
0
Open-market sells
8

Counts cover the 13 most recent Form 4 filings Tradune holds for IBRX (filed Jun 5 – Oct 6, 2026); the score below covers only the trailing 90 days (0 buys, 2 sells). SEC EDGAR Form 4 filings for IBRX last checked Nov 22, 2026, 09:00 UTC; the latest IBRX filing Tradune holds was filed Oct 6, 2026. This is not guaranteed to be the complete record — see IBRX's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 2 filings Tradune holds for IBRX filed Oct 6, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

2 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
2 sales· 106,056 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Cheryl CohenDirector 0 1 — 81,056 −$851,088
Barry J. SimonDirector 0 1 — 25,000 −$268,760

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 2 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at IBRX

No open-market insider purchases (Form 4 code P) were reported for IBRX between Jun 5, 2026 and Oct 6, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Barry J. Simon Director · filed Oct 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 25,000 $10.75 2,777,788 −0.9% Oct 5, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Cheryl Cohen Director · filed Oct 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Stock Option (right to buy) 55,979 — — — Oct 2, 2026
Option exercise 55,979 $2.98 181,365 +45% Oct 2, 2026
Open-market sale 10b5-1 box checked 81,056 $10.50 100,309 −45% Oct 2, 2026
Cheryl Cohen Director · filed Jul 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 55,979 $2.98 256,596 +28% Jul 2, 2026
Open-market sale 10b5-1 box checked 131,210 $9.50 125,386 −51% Jul 2, 2026
Option exercise Stock Option (right to buy) 55,979 — — — Jul 2, 2026
Christobel Selecky Director · filed Jul 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 124,414 $2.99 159,478 +355% Jul 1, 2026
Option exercise 35,064 $2.98 35,064 — Jul 1, 2026
Open-market sale 10b5-1 box checked 159,478 $9.02 0 −100% Jul 1, 2026
Option exercise Stock Option (right to buy) 124,414 — — — Jul 1, 2026
Option exercise Stock Option (right to buy) 35,064 — — — Jul 1, 2026
Christobel Selecky Director · filed Jul 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 700 $2.98 700 — Jun 30, 2026
Option exercise 300 $2.99 1,000 +43% Jun 30, 2026
Open-market sale 10b5-1 box checked 1,000 $9.00 0 −100% Jun 30, 2026
Option exercise Stock Option (right to buy) 300 — — — Jun 30, 2026
Option exercise Stock Option (right to buy) 700 — — — Jun 30, 2026
Option exercise Stock Option (right to buy) 33,549 — — — Jun 29, 2026
Option exercise 32,173 $2.98 32,173 — Jun 29, 2026
Option exercise 33,549 $2.99 65,722 +104% Jun 29, 2026
Option exercise 30,000 $2.84 95,722 +46% Jun 29, 2026
Open-market sale 10b5-1 box checked 95,722 $9.01 0 −100% Jun 29, 2026
Option exercise Stock Option (right to buy) 32,173 — — — Jun 29, 2026
Option exercise Stock Option (right to buy) 30,000 — — — Jun 29, 2026
Barry J. Simon Director · filed Jun 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 25,000 $7.88 2,802,788 −0.9% Jun 24, 2026
Christobel Selecky Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Linda Maxwell Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Cheryl Cohen Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Michael D. Blaszyk Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Bruce Wendel Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Wesley Clark Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 65,600 — — — Jun 9, 2026
Barry J. Simon Director · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 23,033 $7.18 2,827,788 −0.8% Jun 4, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to IBRX's (Oct 6, 2026).

Frequently asked about IBRX insider activity

How many insiders bought IBRX stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of IBRX shares were reported by ImmunityBio, Inc. insiders between Jun 5, 2026 and Oct 6, 2026. The 13 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for IBRX?

The most recent Form 4 on this page was filed by Cheryl Cohen (Director) on Oct 6, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market IBRX insider sale shown?

The largest open-market sale among the filings shown was 159,478 IBRX shares at $9.02 (about $1,439,066) by Christobel Selecky (Director) on Jul 1, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for IBRX — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.